{"recordsFiltered":50008,"recordsTotal":50008,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-registry_id&start=45600","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-registry_id&start=45000","results":[{"registry_id":"NCT07047690","publication_url":"https://clinicaltrials.gov/study/NCT07047690","title":"A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of Nemolizumab in Adult Patients With Systemic Sclerosis","has_exemption":false,"start_date":"2026-02-20","completion_date":"2028-05-28","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06230224","publication_url":"https://clinicaltrials.gov/study/NCT06230224","title":"A Phase 3, Randomized, Open Label Study Evaluating the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, Versus Standard of Care Therapy in Participants With Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma (OLYMPIA-4)","has_exemption":false,"start_date":"2024-02-15","completion_date":"2028-05-29","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06012695","publication_url":"https://clinicaltrials.gov/study/NCT06012695","title":"A Phase Ib/II, Open-label Study of NBM-BMX as Monotherapy or in Combination With Radiotherapy and Temozolomide in Subjects With Solid Tumors or Newly Diagnosed Glioblastoma","has_exemption":false,"start_date":"2023-08-11","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"Novelwise Pharmaceutical Corporation","sponsor_slug":"novelwise-pharmaceutical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06452186","publication_url":"https://clinicaltrials.gov/study/NCT06452186","title":"Toward Restoration of Normative Postural Control and Stability Using Neural Control of Powered Prosthetic Ankles","has_exemption":false,"start_date":"2023-10-01","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"North Carolina State University","sponsor_slug":"north-carolina-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06986993","publication_url":"https://clinicaltrials.gov/study/NCT06986993","title":"Impact of Semaglutide Administration on Tobacco Use Behavior and Related Mechanisms Among Smokers With Obesity","has_exemption":false,"start_date":"2024-07-01","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06266611","publication_url":"https://clinicaltrials.gov/study/NCT06266611","title":"Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC","has_exemption":false,"start_date":"2024-09-16","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Boulder","sponsor_slug":"university-of-colorado-boulder","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06824415","publication_url":"https://clinicaltrials.gov/study/NCT06824415","title":"Optimizing Depression Treatment Through Sleep-state Brain Stimulation","has_exemption":false,"start_date":"2025-05-01","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06949228","publication_url":"https://clinicaltrials.gov/study/NCT06949228","title":"Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial","has_exemption":false,"start_date":"2025-07-30","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"ProMedica Health System","sponsor_slug":"promedica-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218926","publication_url":"https://clinicaltrials.gov/study/NCT07218926","title":"A Phase 3, Randomized, Multicenter, Open-Label Study of IDRX-42 (GSK6042981) Versus Sunitinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) After Imatinib Therapy (StrateGIST 3)","has_exemption":false,"start_date":"2025-12-03","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06918977","publication_url":"https://clinicaltrials.gov/study/NCT06918977","title":"Evaluation of a Novel Telemedicine Clinic for Patients With DM2 on Multiple Daily Insulin (MDI) Regimens","has_exemption":false,"start_date":"2026-01-30","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282574","publication_url":"https://clinicaltrials.gov/study/NCT07282574","title":"A Multi-center, Double-blind, Placebo-controlled, Phase II Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489, a Monoacylglycerol Lipase Inhibitor, as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis","has_exemption":false,"start_date":"2026-03-10","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07422311","publication_url":"https://clinicaltrials.gov/study/NCT07422311","title":"A Phase 2/3, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"Benuvia Therapeutics Inc.","sponsor_slug":"benuvia-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07527273","publication_url":"https://clinicaltrials.gov/study/NCT07527273","title":"Cognitive Enhancement in Recurrent Depression (The COG-D-R Study)","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03047746","publication_url":"https://clinicaltrials.gov/study/NCT03047746","title":"Unrelated And Partially Matched Related Donor Peripheral Blood Stem Cell Transplantation (PSCT) With TCR αβ + T Cell And B Cell Depletion For Patients With Acquired And Inherited Bone Marrow Failure","has_exemption":false,"start_date":"2017-02-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03331380","publication_url":"https://clinicaltrials.gov/study/NCT03331380","title":"Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System","has_exemption":false,"start_date":"2018-01-05","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03422302","publication_url":"https://clinicaltrials.gov/study/NCT03422302","title":"Measuring the Effectiveness of a Continuous Positive Airway Pressure (CPAP) Device to Reduce Tumor Motion and Increase Lung Volume Expansion in Patients Undergoing Stereotactic Body Radiotherapy (SBRT) for Tumors That Move With Respiration","has_exemption":false,"start_date":"2018-03-16","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03417297","publication_url":"https://clinicaltrials.gov/study/NCT03417297","title":"A Pilot Open-label Clinical Trial Evaluating the ExAblate Model 4000 Type-1 Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy","has_exemption":false,"start_date":"2018-04-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03526835","publication_url":"https://clinicaltrials.gov/study/NCT03526835","title":"Phase 1/2 Dose Escalation and Cohort Expansion Study Evaluating MCLA-158 (Petosemtamab) as Single Agent or in Combination in Advanced Solid Tumors","has_exemption":false,"start_date":"2018-05-02","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Merus B.V.","sponsor_slug":"merus-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04471974","publication_url":"https://clinicaltrials.gov/study/NCT04471974","title":"A Phase 2 Study of BET Bromodomain Inhibitor ZEN-3694 in Combination With Enzalutamide Plus Pembrolizumab in Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-01-26","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Rahul Aggarwal","sponsor_slug":"rahul-aggarwal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03742414","publication_url":"https://clinicaltrials.gov/study/NCT03742414","title":"SEAL (Stopping Eczema and ALlergy) Study: Prevent the Allergic March by Enhancing the Skin Barrier","has_exemption":false,"start_date":"2021-06-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Kari Nadeau, MD, PhD","sponsor_slug":"kari-nadeau-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05045950","publication_url":"https://clinicaltrials.gov/study/NCT05045950","title":"Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique (ONCO-RT) - A Phase II Trial of Upfront Pulsed Reduced Dose Rate Whole-Brain Radiation Therapy for Brain Metastases","has_exemption":false,"start_date":"2021-11-17","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04629547","publication_url":"https://clinicaltrials.gov/study/NCT04629547","title":"Sleep Trial to Prevent Alzheimer's Disease","has_exemption":false,"start_date":"2022-05-25","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284473","publication_url":"https://clinicaltrials.gov/study/NCT06284473","title":"Intranasal Ketamine as a Supplement to Local Anesthesia to Reduce Pain Associated With Minor Procedures in the Emergency Department","has_exemption":false,"start_date":"2022-05-25","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Loyola University","sponsor_slug":"loyola-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05101070","publication_url":"https://clinicaltrials.gov/study/NCT05101070","title":"A Phase 1b/2, Multicenter, Open-label Study of S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2022-05-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Shionogi","sponsor_slug":"shionogi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04912531","publication_url":"https://clinicaltrials.gov/study/NCT04912531","title":"Using a Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery","has_exemption":false,"start_date":"2022-10-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05508789","publication_url":"https://clinicaltrials.gov/study/NCT05508789","title":"Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease","has_exemption":false,"start_date":"2022-10-10","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05024773","publication_url":"https://clinicaltrials.gov/study/NCT05024773","title":"A Phase III, Single-arm Study to Evaluate the Efficacy and Safety of ONCOFID-P-B (Paclitaxel-hyaluronic Acid Conjugate) Administered Intravesically to Patients With BCG-unresponsive Carcinoma in Situ of the Bladder With or Without Ta-T1 Papillary Disease (Orion-BC)","has_exemption":false,"start_date":"2022-12-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Fidia Farmaceutici s.p.a.","sponsor_slug":"fidia-farmaceutici-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05528133","publication_url":"https://clinicaltrials.gov/study/NCT05528133","title":"Phase II Study of Genomically Guided Radiation Dose Personalization in the Management of Triple Negative Breast Cancer","has_exemption":false,"start_date":"2023-01-25","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05896293","publication_url":"https://clinicaltrials.gov/study/NCT05896293","title":"Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders","has_exemption":false,"start_date":"2023-02-03","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Stephanie B. Seminara, MD","sponsor_slug":"stephanie-b-seminara-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04796792","publication_url":"https://clinicaltrials.gov/study/NCT04796792","title":"Ultrasound Technology to Fragment and Reposition Urinary Stones","has_exemption":false,"start_date":"2023-04-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05737199","publication_url":"https://clinicaltrials.gov/study/NCT05737199","title":"A Single-arm Open-label Phase II Trial to Assess the Efficacy and Safety of Pembrolizumab for Unresectable Advanced or Recurrent Ovarian Squamous Cell Carcinoma","has_exemption":false,"start_date":"2023-05-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Niigata University Medical & Dental Hospital","sponsor_slug":"niigata-university-medical-dental-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05943210","publication_url":"https://clinicaltrials.gov/study/NCT05943210","title":"The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer.","has_exemption":false,"start_date":"2023-05-22","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05805839","publication_url":"https://clinicaltrials.gov/study/NCT05805839","title":"Advanced MR and PET Imaging in Inflammatory Demyelinating Diseases of the Central Nervous System","has_exemption":false,"start_date":"2023-07-10","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04419272","publication_url":"https://clinicaltrials.gov/study/NCT04419272","title":"Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits: a Randomized, Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2023-08-14","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06023589","publication_url":"https://clinicaltrials.gov/study/NCT06023589","title":"A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children With Severe Uncontrolled Asthma (HORIZON)","has_exemption":false,"start_date":"2023-08-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05948553","publication_url":"https://clinicaltrials.gov/study/NCT05948553","title":"A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members, Veterans, and Non-Veteran Civilians With PTSD","has_exemption":false,"start_date":"2023-11-02","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Global Coalition for Adaptive Research","sponsor_slug":"global-coalition-for-adaptive-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05948943","publication_url":"https://clinicaltrials.gov/study/NCT05948943","title":"A Two-stage Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.","has_exemption":false,"start_date":"2023-11-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003348","publication_url":"https://clinicaltrials.gov/study/NCT06003348","title":"Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones","has_exemption":false,"start_date":"2023-12-13","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06305039","publication_url":"https://clinicaltrials.gov/study/NCT06305039","title":"Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments - Part 2","has_exemption":false,"start_date":"2023-12-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, College Park","sponsor_slug":"university-of-maryland-college-park","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06094192","publication_url":"https://clinicaltrials.gov/study/NCT06094192","title":"Personalized Synchronization of Cortical Rhythms to Improve Memory in Alzheimer's Disease","has_exemption":false,"start_date":"2023-12-20","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston University Charles River Campus","sponsor_slug":"boston-university-charles-river-campus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05483010","publication_url":"https://clinicaltrials.gov/study/NCT05483010","title":"Pilot Study of Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)","has_exemption":false,"start_date":"2024-02-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06347978","publication_url":"https://clinicaltrials.gov/study/NCT06347978","title":"A Double-Blinded, Randomized, Crossover Trial of Stereoencephalography- Guided Four-Lead Personalized Deep Brain Stimulation for Treatment-Refractory Obsessive Compulsive Disorder (SEEG-Guided DBS for OCD)","has_exemption":false,"start_date":"2024-05-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Andrew Moses Lee, MD, PhD","sponsor_slug":"andrew-moses-lee-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06264882","publication_url":"https://clinicaltrials.gov/study/NCT06264882","title":"Cardiometabolic Consequences of the Loss of Ovarian Function","has_exemption":false,"start_date":"2024-06-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06389877","publication_url":"https://clinicaltrials.gov/study/NCT06389877","title":"A Phase 1/2 Dose-exploration and Dose-expansion Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)-Associated Lung Disease and/or Liver Disease","has_exemption":false,"start_date":"2024-06-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Beam Therapeutics Inc.","sponsor_slug":"beam-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05932199","publication_url":"https://clinicaltrials.gov/study/NCT05932199","title":"Combination of Induction Durvalumab and Tremelimumab Alone Versus Durvalumab and Tremelimumab With Chemotherapy for Potentially Resectable Pleural Mesothelioma","has_exemption":false,"start_date":"2024-07-03","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05662462","publication_url":"https://clinicaltrials.gov/study/NCT05662462","title":"ACHIEVE: Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching","has_exemption":false,"start_date":"2024-07-11","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961487","publication_url":"https://clinicaltrials.gov/study/NCT06961487","title":"Endovascular Therapy for Large Core Patients With Uncertain Response to Thrombectomy (OUTER LIMITS)","has_exemption":false,"start_date":"2024-07-26","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06475742","publication_url":"https://clinicaltrials.gov/study/NCT06475742","title":"A Phase 3, Multicenter, Open-label, Single-arm, Extension Study to Evaluate the Long-term Safety and Tolerability of Cenerimod in Adult Subjects With Moderate-to-Severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy","has_exemption":false,"start_date":"2024-07-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06031688","publication_url":"https://clinicaltrials.gov/study/NCT06031688","title":"A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)","has_exemption":false,"start_date":"2024-08-08","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06494072","publication_url":"https://clinicaltrials.gov/study/NCT06494072","title":"Short Versus Standard of Care Antibiotic Duration for Hospitalized Children With Uncomplicated Community-acquired Pneumonia: a Non-inferiority, Randomized Controlled Trial.","has_exemption":false,"start_date":"2024-08-22","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06320366","publication_url":"https://clinicaltrials.gov/study/NCT06320366","title":"Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder","has_exemption":false,"start_date":"2024-09-03","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06240754","publication_url":"https://clinicaltrials.gov/study/NCT06240754","title":"A Pilot Study of Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2: A Decentralized Trial","has_exemption":false,"start_date":"2024-10-10","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06334315","publication_url":"https://clinicaltrials.gov/study/NCT06334315","title":"Influence of Genetics Variants on the Pharmacokinetics and Pharmacodynamics of Combined Oral Contraceptive Pill Users","has_exemption":false,"start_date":"2024-10-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06481592","publication_url":"https://clinicaltrials.gov/study/NCT06481592","title":"A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Endometrial Cancer.","has_exemption":false,"start_date":"2024-10-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Iovance Biotherapeutics, Inc.","sponsor_slug":"iovance-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06116682","publication_url":"https://clinicaltrials.gov/study/NCT06116682","title":"A Phase II Study of Amivantamab SC (Subcutaneous) in Participants With MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)","has_exemption":false,"start_date":"2024-11-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06617325","publication_url":"https://clinicaltrials.gov/study/NCT06617325","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2024-11-21","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06685848","publication_url":"https://clinicaltrials.gov/study/NCT06685848","title":"Multi-Center, Randomized, Controlled Cross-Over Study to Evaluate Safety and Effectiveness of Hypoxic RBCs Processed With the Hemanext ONE System vs Conventional RBCs in Patients With Transfusion-Dependent Haematological Malignancies","has_exemption":false,"start_date":"2024-11-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Hemanext","sponsor_slug":"hemanext","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630234","publication_url":"https://clinicaltrials.gov/study/NCT06630234","title":"A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)","has_exemption":false,"start_date":"2024-12-10","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Deciphera Pharmaceuticals LLC","sponsor_slug":"deciphera-pharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06533748","publication_url":"https://clinicaltrials.gov/study/NCT06533748","title":"SJALL23H: Combination Antigen-Directed Induction Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma","has_exemption":false,"start_date":"2025-01-23","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05671133","publication_url":"https://clinicaltrials.gov/study/NCT05671133","title":"Effectiveness and Implementation of a Clinician Decision Support System to Prevent Suicidal Behaviors","has_exemption":false,"start_date":"2025-02-25","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06857942","publication_url":"https://clinicaltrials.gov/study/NCT06857942","title":"A Phase 4, Prospective, Open-Label, Single Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight in Clinical Practice","has_exemption":false,"start_date":"2025-03-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976853","publication_url":"https://clinicaltrials.gov/study/NCT06976853","title":"Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease","has_exemption":false,"start_date":"2025-05-13","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06984861","publication_url":"https://clinicaltrials.gov/study/NCT06984861","title":"Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Advanced Stage Human Papilloma Virus Associated Oropharyngeal Carcinoma","has_exemption":false,"start_date":"2025-05-13","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06986083","publication_url":"https://clinicaltrials.gov/study/NCT06986083","title":"A Randomized Controlled Trial of Modifications to Prostate Needle-Based Procedures","has_exemption":false,"start_date":"2025-05-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424365","publication_url":"https://clinicaltrials.gov/study/NCT07424365","title":"Investigation of Vagus Nerve Stimulation to Augment Executive Functioning","has_exemption":false,"start_date":"2025-05-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06072898","publication_url":"https://clinicaltrials.gov/study/NCT06072898","title":"Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression","has_exemption":false,"start_date":"2025-05-28","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Sunnybrook Health Sciences Centre","sponsor_slug":"sunnybrook-health-sciences-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06821542","publication_url":"https://clinicaltrials.gov/study/NCT06821542","title":"A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy","has_exemption":false,"start_date":"2025-06-04","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07038200","publication_url":"https://clinicaltrials.gov/study/NCT07038200","title":"A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)","has_exemption":false,"start_date":"2025-06-10","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Avidity Biosciences, Inc.","sponsor_slug":"avidity-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06937099","publication_url":"https://clinicaltrials.gov/study/NCT06937099","title":"A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight","has_exemption":false,"start_date":"2025-06-26","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06925152","publication_url":"https://clinicaltrials.gov/study/NCT06925152","title":"COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block","has_exemption":false,"start_date":"2025-07-15","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Tennessee","sponsor_slug":"university-of-tennessee","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06911632","publication_url":"https://clinicaltrials.gov/study/NCT06911632","title":"MOMENTOUS Study (iMpact Of an Ecg ai ModEl oN The Diagnosis Of pUlmonary hypertenSion)","has_exemption":false,"start_date":"2025-07-23","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Tempus AI","sponsor_slug":"tempus-ai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721013","publication_url":"https://clinicaltrials.gov/study/NCT06721013","title":"A Phase 1/2, Dose-finding Study Investigating the Safety and Efficacy of Pirtobrutinib in Adults With Immune Thrombocytopenia","has_exemption":false,"start_date":"2025-07-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06853184","publication_url":"https://clinicaltrials.gov/study/NCT06853184","title":"Phase 2, Randomized, Open-label, Active Comparator, Dose-ranging Study Evaluating the Efficacy and Safety of Artesunate for Injection in Combination With Ganciclovir or Valganciclovir for the Treatment of Cytomegalovirus Infection in Solid Organ Transplant Recipients","has_exemption":false,"start_date":"2025-08-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Amivas Inc.","sponsor_slug":"amivas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07133308","publication_url":"https://clinicaltrials.gov/study/NCT07133308","title":"A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescent Patients With Severe Alopecia Areata With an Open-label Extension Period","has_exemption":false,"start_date":"2025-08-05","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries, Inc.","sponsor_slug":"sun-pharmaceutical-industries-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07086976","publication_url":"https://clinicaltrials.gov/study/NCT07086976","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Period and Long-term Extension to Assess the Efficacy and Safety of Rilzabrutinib in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)","has_exemption":false,"start_date":"2025-08-18","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07131787","publication_url":"https://clinicaltrials.gov/study/NCT07131787","title":"Optimizing Rehabilitation After Achilles Tendon Rupture Repair: The Role of Blood Flow Restriction Training in Tendon and Muscle Recovery","has_exemption":false,"start_date":"2025-08-20","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Ghent","sponsor_slug":"university-hospital-ghent","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06624475","publication_url":"https://clinicaltrials.gov/study/NCT06624475","title":"Randomized Phase II Trial Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma","has_exemption":false,"start_date":"2025-08-21","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07053059","publication_url":"https://clinicaltrials.gov/study/NCT07053059","title":"Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)","has_exemption":false,"start_date":"2025-08-26","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287163","publication_url":"https://clinicaltrials.gov/study/NCT07287163","title":"Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy","has_exemption":false,"start_date":"2025-10-27","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Praxis Precision Medicines","sponsor_slug":"praxis-precision-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07198451","publication_url":"https://clinicaltrials.gov/study/NCT07198451","title":"Efficacy Evaluation of Submucosal Injection of Gemcitabine in Preventing Recurrence of Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized, Single-Blind, Multicenter Clinical Study","has_exemption":false,"start_date":"2025-10-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Shanghai University of Traditional Chinese Medicine","sponsor_slug":"shanghai-university-of-traditional-chinese-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228832","publication_url":"https://clinicaltrials.gov/study/NCT07228832","title":"A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination With FOLFOX Versus Bevacizumab in Combination With FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2025-11-18","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Summit Therapeutics","sponsor_slug":"summit-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07392255","publication_url":"https://clinicaltrials.gov/study/NCT07392255","title":"A First in Human Phase 1 / 2 Multi-center Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of CTx001 Administered Via a Single Subretinal Injection in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2025-12-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Complement Therapeutics","sponsor_slug":"complement-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284459","publication_url":"https://clinicaltrials.gov/study/NCT07284459","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Oral PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2026-01-08","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Contineum Therapeutics","sponsor_slug":"contineum-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07308925","publication_url":"https://clinicaltrials.gov/study/NCT07308925","title":"Effectiveness of Using Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.","has_exemption":false,"start_date":"2026-01-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Hospital Universitario San Ignacio","sponsor_slug":"hospital-universitario-san-ignacio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325500","publication_url":"https://clinicaltrials.gov/study/NCT07325500","title":"Incretin Microdosing for Cardiometabolic Health in People With HIV: The REINFORCE Trial","has_exemption":false,"start_date":"2026-02-12","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06667726","publication_url":"https://clinicaltrials.gov/study/NCT06667726","title":"A Centralized Protocol Evaluating the Safety and Clinical Impact of Amino Acid Pet for Brain Tumors","has_exemption":false,"start_date":"2026-03-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07527039","publication_url":"https://clinicaltrials.gov/study/NCT07527039","title":"Intraoperative Pectoral Block in Breast Reductions: Reduction in Pain Scores & Elimination of Narcotic Use","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07076212","publication_url":"https://clinicaltrials.gov/study/NCT07076212","title":"Phase II Study Evaluating NALIRIFOX Versus Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-04-02","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523750","publication_url":"https://clinicaltrials.gov/study/NCT07523750","title":"Comparison of Safety and Effectiveness of a VARIPULSE™ PFA Catheter to FARAWAVE™ PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-04-02","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07525076","publication_url":"https://clinicaltrials.gov/study/NCT07525076","title":"Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department","has_exemption":false,"start_date":"2026-04-15","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214844","publication_url":"https://clinicaltrials.gov/study/NCT07214844","title":"A Prospective, Randomized, Assessor Blind, Active-controlled, Single-center Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Facet-mediated Chronic Low Back Pain","has_exemption":false,"start_date":"2026-04-16","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07542041","publication_url":"https://clinicaltrials.gov/study/NCT07542041","title":"Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens (ANoPs)","has_exemption":false,"start_date":"2026-04-17","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"ARTIDIS AG","sponsor_slug":"artidis-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07546500","publication_url":"https://clinicaltrials.gov/study/NCT07546500","title":"A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator's Choice of Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression","has_exemption":false,"start_date":"2026-04-17","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc","sponsor_slug":"k-group-beta-inc-a-wholly-owned-subsidiary-of-zentalis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07485647","publication_url":"https://clinicaltrials.gov/study/NCT07485647","title":"Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing","has_exemption":false,"start_date":"2026-04-20","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eden Biltibo","sponsor_slug":"eden-biltibo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07637162","publication_url":"https://clinicaltrials.gov/study/NCT07637162","title":"An Open-Label Study to Assess the Long-Term Safety and Efficacy of AXS-14 in the Management of Fibromyalgia","has_exemption":false,"start_date":"2026-04-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Axsome Therapeutics, Inc.","sponsor_slug":"axsome-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06979492","publication_url":"https://clinicaltrials.gov/study/NCT06979492","title":"Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07620262","publication_url":"https://clinicaltrials.gov/study/NCT07620262","title":"Prospective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation Study","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07567014","publication_url":"https://clinicaltrials.gov/study/NCT07567014","title":"A Phase II Study of the Interferon Gamma Inhibitor Emapalumab for Prophylaxis of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Lymphoma and Multiple Myeloma Receiving Bispecific T-Cell Engagers","has_exemption":false,"start_date":"2026-05-11","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07276711","publication_url":"https://clinicaltrials.gov/study/NCT07276711","title":"Controlled Arterial Protection to Ultimately Remove Embolic Material","has_exemption":false,"start_date":"2026-05-12","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"EmStop Inc","sponsor_slug":"emstop-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07587515","publication_url":"https://clinicaltrials.gov/study/NCT07587515","title":"Open-Label, Multiple Ascending Dose Phase 1b/2a Study of the Safety and Tolerability of Intravitreal (IVT) EYC-0305 in Patients With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2026-05-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eyconis INC.","sponsor_slug":"eyconis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07483177","publication_url":"https://clinicaltrials.gov/study/NCT07483177","title":"Hemodynamic Effects Of Aldosterone Receptor Blockade In Degenerative Thoracic Aortic Aneurysm: A Pilot Randomized Controlled Trial (HEART: Pilot RCT)","has_exemption":false,"start_date":"2026-05-25","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07612657","publication_url":"https://clinicaltrials.gov/study/NCT07612657","title":"A Randomized, Double-blind, Placebo-controlled, Safety and Efficacy Study of VI-0106 (Extended-release Tacrolimus) in Subjects With PAH and Functional Limitations Despite Optimized Treatment With Available PAH Medications","has_exemption":false,"start_date":"2026-05-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"VIVUS LLC","sponsor_slug":"vivus-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05874193","publication_url":"https://clinicaltrials.gov/study/NCT05874193","title":"A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Cristiana Costa Chase, DO","sponsor_slug":"cristiana-costa-chase-do","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290998","publication_url":"https://clinicaltrials.gov/study/NCT07290998","title":"A Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Locally Recurrent Prostate Cancer","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Alpha Tau Medical LTD.","sponsor_slug":"alpha-tau-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07459114","publication_url":"https://clinicaltrials.gov/study/NCT07459114","title":"An Adaptive Dose Escalation and Expansion Basket Trial to Explore the Safety, Pharmacology, and Clinical Activity of TGD001 in Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) and Other Thrombotic Microangiopathies","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"TargED Biopharmaceuticals B.V.","sponsor_slug":"targed-biopharmaceuticals-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07510945","publication_url":"https://clinicaltrials.gov/study/NCT07510945","title":"A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3b Clinical Study to Evaluate the Efficacy and Safety of HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","sponsor_slug":"haisco-pharmaceutical-group-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566208","publication_url":"https://clinicaltrials.gov/study/NCT07566208","title":"Using Mirabegron to Control Arrhythmia-1","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07568756","publication_url":"https://clinicaltrials.gov/study/NCT07568756","title":"Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07585513","publication_url":"https://clinicaltrials.gov/study/NCT07585513","title":"A Randomized Placebo-Controlled Clinical Trial Evaluating Mirabegron's Effectiveness in Alleviating POTS Symptoms","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07690371","publication_url":"https://clinicaltrials.gov/study/NCT07690371","title":"A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rezpegaldesleukin (NKTR-358) Monotherapy in the Treatment of Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2026-06-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Nektar Therapeutics","sponsor_slug":"nektar-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07484139","publication_url":"https://clinicaltrials.gov/study/NCT07484139","title":"H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07567495","publication_url":"https://clinicaltrials.gov/study/NCT07567495","title":"Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07598357","publication_url":"https://clinicaltrials.gov/study/NCT07598357","title":"Salvaged Red Blood Cell Transfusion During Pancreatic Adenocarcinoma Operations","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07383649","publication_url":"https://clinicaltrials.gov/study/NCT07383649","title":"Initial Safety Lead-in Followed by a Phase II Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection (The Breast CMV Study)","has_exemption":false,"start_date":"2026-07-14","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07296874","publication_url":"https://clinicaltrials.gov/study/NCT07296874","title":"Acute Effects of Cannabis on Cognition and Affect","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington State University","sponsor_slug":"washington-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07643467","publication_url":"https://clinicaltrials.gov/study/NCT07643467","title":"Fluorescent Probe for Assessment of Renal Elimination","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Aaron Cook","sponsor_slug":"aaron-cook","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07643493","publication_url":"https://clinicaltrials.gov/study/NCT07643493","title":"Utility of Continuous Intrathecal TPA Infusion for IVH Clearance With Ventricular Irrigation","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"David Dornbos","sponsor_slug":"david-dornbos","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07695298","publication_url":"https://clinicaltrials.gov/study/NCT07695298","title":"A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome [PLANE Study]","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Cincinnati Eye Institute, Southwest Ohio","sponsor_slug":"cincinnati-eye-institute-southwest-ohio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07348796","publication_url":"https://clinicaltrials.gov/study/NCT07348796","title":"Real World Evaluation of the Effectiveness and Implementation of a Digital Health Therapeutic for Opioid Use Disorder (OUD)","has_exemption":false,"start_date":"2026-08-17","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07247162","publication_url":"https://clinicaltrials.gov/study/NCT07247162","title":"A Double-blind, Randomised, 30-week Placebo-controlled Phase IV Study to Assess the Efficacy and Safety of Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"RECORDATI GROUP","sponsor_slug":"recordati-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06550999","publication_url":"https://clinicaltrials.gov/study/NCT06550999","title":"Patient Satisfaction and Cosmetic Outcomes in Adhesive Strip Versus Suture Repair for Simple Facial Lacerations: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07668817","publication_url":"https://clinicaltrials.gov/study/NCT07668817","title":"Defining the Role of Hemostatic Agents in Percutaneous Nephrolithotomy: A Randomized Controlled Trial of Tract Closure Techniques","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07669207","publication_url":"https://clinicaltrials.gov/study/NCT07669207","title":"Extended Azithromycin Treatment in Peri-viable and Extremely Preterm Prelabor Rupture of Membranes: A Pilot Study","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Alexa Henderson","sponsor_slug":"alexa-henderson","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07759245","publication_url":"https://clinicaltrials.gov/study/NCT07759245","title":"A Phase 2, Multicenter, Randomized, Double-Blind, 52-week Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325201","publication_url":"https://clinicaltrials.gov/study/NCT07325201","title":"Mitigating Diabetic Ketoacidosis in People With T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation Into an Enhanced Glucose Ketone Report","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"HealthPartners Institute","sponsor_slug":"healthpartners-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07646210","publication_url":"https://clinicaltrials.gov/study/NCT07646210","title":"A Phase I/IIa, Open-Label, Dose Escalation Study to Evaluate the Safety and Tolerability of HiCM-188, an Allogeneic iPSC-derived Cardiomyocyte Therapy, in Adult Patients With Advanced Heart Failure","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"HELP Therapeutics Co., Ltd.","sponsor_slug":"help-therapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07651956","publication_url":"https://clinicaltrials.gov/study/NCT07651956","title":"Remimazolam Versus Dexmedetomidine for Procedural Sedation During Neuraxial Anesthesia Placement For Scheduled Cesarean Delivery","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07733934","publication_url":"https://clinicaltrials.gov/study/NCT07733934","title":"A Randomized, Double-Blind, Placebo-Controlled, Multi-centre Study to Evaluate the Effects of Teverelix DP, a GnRH Antagonist, on Prostate Volume, Urinary Function and Clinical Outcomes in Men Following a First Episode of Acute Urinary Retention (AUR)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Antev Ltd.","sponsor_slug":"antev-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07148206","publication_url":"https://clinicaltrials.gov/study/NCT07148206","title":"Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209215","publication_url":"https://clinicaltrials.gov/study/NCT07209215","title":"ULtra sensiTive ctDNA-Informed Management eArly-stage recTal cancEr (ULTIMATE)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07458217","publication_url":"https://clinicaltrials.gov/study/NCT07458217","title":"Combined CM and STN Stimulation for Motor Epilepsy","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07083765","publication_url":"https://clinicaltrials.gov/study/NCT07083765","title":"A Prospective Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation Using the Dehydrated Alcohol Injection, USP Administered With the Peregrine System™ Infusion Catheter in Subjects With Hypertension, in the Absence of Antihypertensive Medications","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Ablative Solutions, Inc.","sponsor_slug":"ablative-solutions-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07636356","publication_url":"https://clinicaltrials.gov/study/NCT07636356","title":"Development of Tetrahydrocannabivarin as a Treatment for Smokers","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07738107","publication_url":"https://clinicaltrials.gov/study/NCT07738107","title":"A Phase 1/2, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous ATR 1072 for the Treatment of PRKAG2 Syndrome","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Atrium Therapeutics","sponsor_slug":"atrium-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07180576","publication_url":"https://clinicaltrials.gov/study/NCT07180576","title":"The FORCE Trial Pilot","has_exemption":false,"start_date":"2027-06-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Anna Arthur, PhD","sponsor_slug":"anna-arthur-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06362187","publication_url":"https://clinicaltrials.gov/study/NCT06362187","title":"A Feasibility Study on Gut-Directed Virtual Reality for Chronic Pain Related to Chronic Pancreatitis","has_exemption":false,"start_date":"2027-07-22","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05948579","publication_url":"https://clinicaltrials.gov/study/NCT05948579","title":"A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members, Veterans, and Non-Veteran Civilians With PTSD","has_exemption":false,"start_date":"2027-08-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Global Coalition for Adaptive Research","sponsor_slug":"global-coalition-for-adaptive-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00882895","publication_url":"https://clinicaltrials.gov/study/NCT00882895","title":"Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2009-05-05","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01950351","publication_url":"https://clinicaltrials.gov/study/NCT01950351","title":"Phase II Trial of Hypofractionated Proton Beam Therapy in Men With Localized Prostate Adenocarcinoma","has_exemption":false,"start_date":"2013-10-10","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02156739","publication_url":"https://clinicaltrials.gov/study/NCT02156739","title":"Radiologic Detection and Characterization of Benign and Malignant Liver Lesions in Contrast-Enhanced MRI","has_exemption":false,"start_date":"2014-10-13","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03080974","publication_url":"https://clinicaltrials.gov/study/NCT03080974","title":"Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2017-08-14","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02708836","publication_url":"https://clinicaltrials.gov/study/NCT02708836","title":"Limiting Emergence Phenomena After General Anesthesia for Laparoscopic Surgery With Combined Laryngeal Mask Airway and Endotracheal Tube Airway Management Technique","has_exemption":false,"start_date":"2020-01-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04493164","publication_url":"https://clinicaltrials.gov/study/NCT04493164","title":"Phase II Investigator Sponsored Study of CPX-351 in Combination With Ivosidenib for Patients With IDH1 Mutated Acute Myeloid Leukemia or High-Risk MDS","has_exemption":false,"start_date":"2020-12-30","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04891510","publication_url":"https://clinicaltrials.gov/study/NCT04891510","title":"A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery","has_exemption":false,"start_date":"2021-05-19","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05381103","publication_url":"https://clinicaltrials.gov/study/NCT05381103","title":"PSMA-PET to Guide Prostatectomy: A Randomized Trial","has_exemption":false,"start_date":"2021-10-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Five Eleven Pharma, Inc.","sponsor_slug":"five-eleven-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04986579","publication_url":"https://clinicaltrials.gov/study/NCT04986579","title":"Assessing the Impact of Scalp Cooling in With Metastatic Breast Cancer","has_exemption":false,"start_date":"2021-10-07","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04883671","publication_url":"https://clinicaltrials.gov/study/NCT04883671","title":"Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial","has_exemption":false,"start_date":"2021-12-27","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05150197","publication_url":"https://clinicaltrials.gov/study/NCT05150197","title":"Virtual Reality Visual Field Testing as an Alternative to Standard Automated Perimetry in Childhood Eye Disease","has_exemption":false,"start_date":"2022-01-19","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05331144","publication_url":"https://clinicaltrials.gov/study/NCT05331144","title":"Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid, and Tau in Older Adults (IPAT Study)","has_exemption":false,"start_date":"2022-10-25","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Rong Zhang","sponsor_slug":"rong-zhang","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05928936","publication_url":"https://clinicaltrials.gov/study/NCT05928936","title":"Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD","has_exemption":false,"start_date":"2022-11-11","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06104618","publication_url":"https://clinicaltrials.gov/study/NCT06104618","title":"Phase II Study of Enfortumab Vedotin Treatment for Metastatic Squamous Cell Carcinoma of the Penis","has_exemption":false,"start_date":"2023-12-21","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06027879","publication_url":"https://clinicaltrials.gov/study/NCT06027879","title":"Anti-viral T-cell Therapy by Gamma Capture for High-risk Patients With Acquired or Inherited Immune Defects","has_exemption":false,"start_date":"2024-01-08","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Paul Szabolcs","sponsor_slug":"paul-szabolcs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06610305","publication_url":"https://clinicaltrials.gov/study/NCT06610305","title":"Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression: A Crossover Randomized Controlled Trial","has_exemption":false,"start_date":"2024-09-02","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06070350","publication_url":"https://clinicaltrials.gov/study/NCT06070350","title":"Massive Transfusion in Children: a Platform RCT of Whole Blood Compared to Component Therapy and Tranexamic Acid to Placebo in Life-threatening Traumatic Bleeding","has_exemption":false,"start_date":"2024-11-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Philip Spinella","sponsor_slug":"philip-spinella","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06731478","publication_url":"https://clinicaltrials.gov/study/NCT06731478","title":"A Multicenter, Randomized, Open-Label, Phase 3 Trial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab Versus Chemotherapy Plus Trastuzumab Plus or Minus Pembrolizumab as First-Line Treatment in Participants With Unresectable, Locally Advanced or Metastatic HER2-Positive Gastric Or Gastroesophageal Junction (GEJ) Cancer (Destiny-Gastric05)","has_exemption":false,"start_date":"2025-02-27","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06644781","publication_url":"https://clinicaltrials.gov/study/NCT06644781","title":"A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)","has_exemption":false,"start_date":"2025-03-27","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06397274","publication_url":"https://clinicaltrials.gov/study/NCT06397274","title":"A Phase II, Randomized, Double-Blind, Placebo-controlled, Single-Center Study to Evaluate the Safety and Efficacy of Stemchymal (Allogeneic Adipose-derived Mesenchymal Stem Cells) Infusion for the Treatment of PolyQ Spinocerebellar Ataxia","has_exemption":false,"start_date":"2025-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Steminent US, Inc.","sponsor_slug":"steminent-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07071402","publication_url":"https://clinicaltrials.gov/study/NCT07071402","title":"A Single-center, Single-arm, Open Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery","has_exemption":false,"start_date":"2025-07-18","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Xijing Hospital","sponsor_slug":"xijing-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06503146","publication_url":"https://clinicaltrials.gov/study/NCT06503146","title":"18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection","has_exemption":false,"start_date":"2025-09-09","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07198724","publication_url":"https://clinicaltrials.gov/study/NCT07198724","title":"ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer","has_exemption":false,"start_date":"2025-11-17","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Kristina A. Fanucci","sponsor_slug":"kristina-a-fanucci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287839","publication_url":"https://clinicaltrials.gov/study/NCT07287839","title":"Phase-2 Trial of Parcel-guided rTMS for Major Depressive Disorder","has_exemption":false,"start_date":"2025-12-15","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Soterix Medical","sponsor_slug":"soterix-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07689357","publication_url":"https://clinicaltrials.gov/study/NCT07689357","title":"Comparison of Labor Induction With Cervical Ripening Balloon, 3 Hours vs 12 Hours Placement: a Randomized Controlled Trail","has_exemption":false,"start_date":"2026-05-27","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Rambam Health Care Campus","sponsor_slug":"rambam-health-care-campus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07349771","publication_url":"https://clinicaltrials.gov/study/NCT07349771","title":"Phase II Double-Blinded Placebo-Controlled Randomized Trial of CSF-1R Inhibitor, Axatilimab for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS)","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07438626","publication_url":"https://clinicaltrials.gov/study/NCT07438626","title":"Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07494435","publication_url":"https://clinicaltrials.gov/study/NCT07494435","title":"An Open-Label Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma or Advance Renal Cell Carcinoma","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Zhejiang Haichang Biotech Co., Ltd.","sponsor_slug":"zhejiang-haichang-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07567729","publication_url":"https://clinicaltrials.gov/study/NCT07567729","title":"A Pilot Study to Evaluate the Feasibility of EEG-guided Anesthesia Protocol to Reduce POD","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07592767","publication_url":"https://clinicaltrials.gov/study/NCT07592767","title":"Multicenter, Randomized, Double Blind, Placebo-Controlled Phase 2a Study, to Evaluate Safety, Tolerability and Pharmacokinetics of Resveratrol (JOTROLTM) in Parkinson's Disease","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07674043","publication_url":"https://clinicaltrials.gov/study/NCT07674043","title":"Continuous Compartment Pressure Monitoring in Adolescent Tibia Fractures","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07605546","publication_url":"https://clinicaltrials.gov/study/NCT07605546","title":"Functional Radiosurgery for Easing or Eliminating Debilitating Oncologic Morbidity (FREEDOM)","has_exemption":false,"start_date":"2026-06-09","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07587775","publication_url":"https://clinicaltrials.gov/study/NCT07587775","title":"The Effect of Osteoporotic Medications on Vertebral Bone Quality Score","has_exemption":false,"start_date":"2026-06-18","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07599865","publication_url":"https://clinicaltrials.gov/study/NCT07599865","title":"Using Ultrasound and Microbubbles to Augment Antibiotic Efficiency Against Periprosthetic Joint Infections","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290985","publication_url":"https://clinicaltrials.gov/study/NCT07290985","title":"AACR Adaptive Biomarker-Driven Organ Preservation Trial In Gastroesophageal Adenocarcinomas (AACR-ADOPT-GEA)","has_exemption":false,"start_date":"2026-07-20","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"American Association for Cancer Research","sponsor_slug":"american-association-for-cancer-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07756398","publication_url":"https://clinicaltrials.gov/study/NCT07756398","title":"Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)","has_exemption":false,"start_date":"2026-08-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07507214","publication_url":"https://clinicaltrials.gov/study/NCT07507214","title":"Optimized, Neuroplasticity Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07643428","publication_url":"https://clinicaltrials.gov/study/NCT07643428","title":"Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors (CLARA)","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04747236","publication_url":"https://clinicaltrials.gov/study/NCT04747236","title":"A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)","has_exemption":false,"start_date":"2021-02-19","completion_date":"2028-06-02","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05312879","publication_url":"https://clinicaltrials.gov/study/NCT05312879","title":"A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-mediated Proteinuric Kidney Disease","has_exemption":false,"start_date":"2022-03-30","completion_date":"2028-06-02","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05481827","publication_url":"https://clinicaltrials.gov/study/NCT05481827","title":"ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study","has_exemption":false,"start_date":"2022-07-12","completion_date":"2028-06-02","has_results":false,"results_due":false,"sponsor_name":"Gyroscope Therapeutics Limited","sponsor_slug":"gyroscope-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06113302","publication_url":"https://clinicaltrials.gov/study/NCT06113302","title":"A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)","has_exemption":false,"start_date":"2024-03-01","completion_date":"2028-06-02","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06769698","publication_url":"https://clinicaltrials.gov/study/NCT06769698","title":"Phase II Randomized Study of Fianlimab Plus Cemiplimab Versus Cemiplimab Plus Placebo in First-Line Treatment of Participants With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Is Positive for PD-L1 Expression","has_exemption":false,"start_date":"2026-04-14","completion_date":"2028-06-04","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07014917","publication_url":"https://clinicaltrials.gov/study/NCT07014917","title":"Randomized Phase II Study of Intermittent Versus Continuous Venetoclax Therapy With Acalabrutinib in Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This","has_exemption":false,"start_date":"2025-12-05","completion_date":"2028-06-05","has_results":false,"results_due":false,"sponsor_name":"Zulfa Omer","sponsor_slug":"zulfa-omer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453876","publication_url":"https://clinicaltrials.gov/study/NCT06453876","title":"Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)","has_exemption":false,"start_date":"2026-06-17","completion_date":"2028-06-05","has_results":false,"results_due":false,"sponsor_name":"Jesper Kjaergaard","sponsor_slug":"jesper-kjaergaard","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06824168","publication_url":"https://clinicaltrials.gov/study/NCT06824168","title":"A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia in Complete Remission","has_exemption":false,"start_date":"2025-07-18","completion_date":"2028-06-06","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07088068","publication_url":"https://clinicaltrials.gov/study/NCT07088068","title":"A Randomized, Double-blind, Phase 3 Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Recently Diagnosed Stage 3 Type 1 Diabetes (T1D)","has_exemption":false,"start_date":"2025-08-06","completion_date":"2028-06-06","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06794229","publication_url":"https://clinicaltrials.gov/study/NCT06794229","title":"A Phase II, Open-label, Single-arm Study of nEoadjuvant Zanzalintinib (XL092) Plus nivoLumab in Patients With lOcally Advanced and/or inopeRable clEar Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis (EXPLORE-RCC)","has_exemption":false,"start_date":"2025-10-30","completion_date":"2028-06-06","has_results":false,"results_due":false,"sponsor_name":"Qian Qin","sponsor_slug":"qian-qin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07431177","publication_url":"https://clinicaltrials.gov/study/NCT07431177","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase IIb Study to Assess the Efficacy and Safety of GIA632 in Adult Participants With Non-segmental Vitiligo Followed by an Extension Period","has_exemption":false,"start_date":"2026-03-09","completion_date":"2028-06-06","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07503210","publication_url":"https://clinicaltrials.gov/study/NCT07503210","title":"Efficacy and Safety of NNC0487-0111 s.c. Once Weekly in Participants With Obesity Who Have Reached Target Dose During run-in Period (AMAZE 12)","has_exemption":false,"start_date":"2026-04-21","completion_date":"2028-06-06","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04947254","publication_url":"https://clinicaltrials.gov/study/NCT04947254","title":"Phase II Trial of Primary Radiotherapy With Androgen Ablation With or Without Adjuvant Niraparib for Selected High-Risk Locoregional Prostate Cancer","has_exemption":false,"start_date":"2021-08-05","completion_date":"2028-06-07","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05017025","publication_url":"https://clinicaltrials.gov/study/NCT05017025","title":"A Phase Ib/II Trial to Evaluate Safety, Tolerability and Efficacy of Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for Patients With EGFR-Mutant Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2022-02-17","completion_date":"2028-06-07","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07169578","publication_url":"https://clinicaltrials.gov/study/NCT07169578","title":"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)","has_exemption":false,"start_date":"2025-09-17","completion_date":"2028-06-07","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07170150","publication_url":"https://clinicaltrials.gov/study/NCT07170150","title":"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)","has_exemption":false,"start_date":"2025-11-12","completion_date":"2028-06-07","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06261060","publication_url":"https://clinicaltrials.gov/study/NCT06261060","title":"Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder","has_exemption":false,"start_date":"2024-06-20","completion_date":"2028-06-11","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06902272","publication_url":"https://clinicaltrials.gov/study/NCT06902272","title":"A Phase 2 Study of Circulating Tumor DNA to Predict Response to Neoadjuvant Treatment and De-escalation Adjuvant Immunotherapy in Early-Stage NSCLC (DNA-PREDICT)","has_exemption":false,"start_date":"2025-06-11","completion_date":"2028-06-11","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06467357","publication_url":"https://clinicaltrials.gov/study/NCT06467357","title":"DESTINY-Biliary Tract Cancer-01: A Phase 3 Study of Trastuzumab Deruxtecan (T-DXd) and Rilvegostomig Versus Standard-of-Care Gemcitabine, Cisplatin, and Durvalumab for First Line Locally Advanced or Metastatic HER2-expressing Biliary Tract Cancer","has_exemption":false,"start_date":"2024-08-12","completion_date":"2028-06-12","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07577843","publication_url":"https://clinicaltrials.gov/study/NCT07577843","title":"A Phase 3, Randomized, Double-blind, and Active-controlled Multicenter Study to Evaluate the Efficacy and Safety of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2026-05-22","completion_date":"2028-06-12","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07007637","publication_url":"https://clinicaltrials.gov/study/NCT07007637","title":"A Phase 3, Multicenter, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-06-27","completion_date":"2028-06-13","has_results":false,"results_due":false,"sponsor_name":"MoonLake Immunotherapeutics AG","sponsor_slug":"moonlake-immunotherapeutics-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06929273","publication_url":"https://clinicaltrials.gov/study/NCT06929273","title":"A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania With Mixed Features in Bipolar-I Disorder (BALSAM-3)","has_exemption":false,"start_date":"2025-07-18","completion_date":"2028-06-13","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07391657","publication_url":"https://clinicaltrials.gov/study/NCT07391657","title":"A Phase III Open-label, Randomised, Multicentre Study Comparing AZD0120, a Dual-Targeting Autologous Chimeric Antigen Receptor T-cell (CART) Therapy Directed Against BCMA and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma.","has_exemption":false,"start_date":"2026-02-23","completion_date":"2028-06-14","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07613437","publication_url":"https://clinicaltrials.gov/study/NCT07613437","title":"GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial","has_exemption":false,"start_date":"2026-06-15","completion_date":"2028-06-14","has_results":false,"results_due":false,"sponsor_name":"Chinese University of Hong Kong","sponsor_slug":"chinese-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05039619","publication_url":"https://clinicaltrials.gov/study/NCT05039619","title":"A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescent Patients With Active Class III or IV Lupus Nephritis, Including an Evaluation of Open Label Safety and PK in a Cohort of Pediatric Patients (Aged 5 to < 12)","has_exemption":false,"start_date":"2022-05-12","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04930653","publication_url":"https://clinicaltrials.gov/study/NCT04930653","title":"A Phase II Study of Combination Extracorporeal Photopheresis (ECP) and Mogamulizumab in Erythrodermic CTCL","has_exemption":false,"start_date":"2022-10-19","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05588323","publication_url":"https://clinicaltrials.gov/study/NCT05588323","title":"A Phase 1/2, Multicentre, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Naldemedine in Paediatric Patients Who Are Receiving or Who Are About to Receive Treatment With Opioids","has_exemption":false,"start_date":"2023-01-04","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Shionogi","sponsor_slug":"shionogi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327686","publication_url":"https://clinicaltrials.gov/study/NCT05327686","title":"Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)","has_exemption":false,"start_date":"2023-02-01","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"NRG Oncology","sponsor_slug":"nrg-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05616793","publication_url":"https://clinicaltrials.gov/study/NCT05616793","title":"An Open Label, Dose Exploration, Safety and Tolerability Study of a Subretinal Injection of an OPGx-001 Gene Vector to Participants With LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) With OCncurrent Non-Interventional Follow-Up of Untreated Patients","has_exemption":false,"start_date":"2023-06-15","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Opus Genetics, Inc","sponsor_slug":"opus-genetics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05096481","publication_url":"https://clinicaltrials.gov/study/NCT05096481","title":"Phase 2 Trial of a Novel Peptide Vaccine (PEP-CMV) Targeting CMV Antigen for Newly Diagnosed Pediatric High-grade Glioma and Diffuse Intrinsic Pontine Glioma and Recurrent Medulloblastoma","has_exemption":false,"start_date":"2024-07-18","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06459180","publication_url":"https://clinicaltrials.gov/study/NCT06459180","title":"A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (TroFuse-020/GOG-3101/ENGOT-cx20)","has_exemption":false,"start_date":"2024-07-24","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06506279","publication_url":"https://clinicaltrials.gov/study/NCT06506279","title":"Motor Recovery Through Plasticity-Inducing Cortical Stimulation","has_exemption":false,"start_date":"2025-07-22","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06738407","publication_url":"https://clinicaltrials.gov/study/NCT06738407","title":"Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Among Adolescent and Young Adult Females in the United States","has_exemption":false,"start_date":"2026-02-27","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Westat","sponsor_slug":"westat","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06290609","publication_url":"https://clinicaltrials.gov/study/NCT06290609","title":"Control of Incomplete Spinal Cord Injury-Related Spasticity by Means of Vibrotactile Coordinated Reset Fingertip Stimulation","has_exemption":false,"start_date":"2026-03-15","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293260","publication_url":"https://clinicaltrials.gov/study/NCT07293260","title":"A Double-blind, Randomized, Placebo-controlled, Multi-center Study Evaluating the Safety, Tolerability, and Effect of Olpasiran on Coronary Artery Plaque Burden Assessed by Coronary Computed Tomography Angiography in Participants With Stable Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a)","has_exemption":false,"start_date":"2026-03-23","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07304440","publication_url":"https://clinicaltrials.gov/study/NCT07304440","title":"Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Adia Med of Winter Park LLC","sponsor_slug":"adia-med-of-winter-park-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07512362","publication_url":"https://clinicaltrials.gov/study/NCT07512362","title":"A Pilot Study to Assess the Effect of Adding 1 Infusion of Human Mesenchymal Stem Cells (hMSC) to Patients Treated With Anti-Amyloid Monoclonal Antibodies Who Are Suffering From Mild Cognitive Impairment or Mild Alzheimer's Disease.","has_exemption":false,"start_date":"2026-05-15","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Bernard (Barry) Baumel","sponsor_slug":"bernard-barry-baumel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07167862","publication_url":"https://clinicaltrials.gov/study/NCT07167862","title":"Optimizing Preeclampsia Postpartum With Point-of-Care Ultrasound: A Pilot Prospective Cohort Study","has_exemption":false,"start_date":"2026-06-15","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02621021","publication_url":"https://clinicaltrials.gov/study/NCT02621021","title":"A Phase II Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab","has_exemption":false,"start_date":"2015-12-04","completion_date":"2028-06-16","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05904080","publication_url":"https://clinicaltrials.gov/study/NCT05904080","title":"Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy","has_exemption":false,"start_date":"2024-02-19","completion_date":"2028-06-16","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06925750","publication_url":"https://clinicaltrials.gov/study/NCT06925750","title":"An Open-label Extension Study to Evaluate Safety and Tolerability of Sotatercept (MK-7962) Administered Using a Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care","has_exemption":false,"start_date":"2025-05-12","completion_date":"2028-06-16","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06554717","publication_url":"https://clinicaltrials.gov/study/NCT06554717","title":"Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV","has_exemption":false,"start_date":"2025-07-10","completion_date":"2028-06-16","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221812","publication_url":"https://clinicaltrials.gov/study/NCT07221812","title":"Continuous Glucose Monitors (CGMs) and Readmission Rates","has_exemption":false,"start_date":"2026-06-18","completion_date":"2028-06-17","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06971744","publication_url":"https://clinicaltrials.gov/study/NCT06971744","title":"Autophagy Maintenance (AUTOMAIN) Therapy in High-Grade Serous Ovarian Cancer: A Phase II Trial","has_exemption":false,"start_date":"2025-12-18","completion_date":"2028-06-18","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07388498","publication_url":"https://clinicaltrials.gov/study/NCT07388498","title":"A Phase 3, Multicenter, Double-blind, Randomized Controlled Study Evaluating the Efficacy and Safety of Pegloticase Administered by Subcutaneous Injection Compared With Pegloticase Administered by Intravenous Injection, Both Administered Concurrently With Methotrexate Weekly, in Participants With Uncontrolled Gout","has_exemption":false,"start_date":"2026-02-09","completion_date":"2028-06-18","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07112378","publication_url":"https://clinicaltrials.gov/study/NCT07112378","title":"A Randomized Study Evaluating 2 Dose Regimens of Dupilumab in Children ≥6 Months of Age Weighing ≥5 to <15 kg With Active Eosinophilic Esophagitis","has_exemption":false,"start_date":"2025-11-10","completion_date":"2028-06-19","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07444476","publication_url":"https://clinicaltrials.gov/study/NCT07444476","title":"An Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Salanersen (BIIB115) in Participants Aged 15-60 Years With Spinal Muscular Atrophy Who Are Either Treatment-Naïve or Have Previously Been Treated With Risdiplam","has_exemption":false,"start_date":"2026-04-03","completion_date":"2028-06-23","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07578025","publication_url":"https://clinicaltrials.gov/study/NCT07578025","title":"Phase 2, Single-Arm Trial of Zanzalintinib (XL092) With MO-03 (CBM588 Capsule) in Patients With Metastatic Renal Cell Carcinoma (mRCC) After Progression to Immunotherapy","has_exemption":false,"start_date":"2026-11-28","completion_date":"2028-06-24","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06747351","publication_url":"https://clinicaltrials.gov/study/NCT06747351","title":"A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","has_exemption":false,"start_date":"2025-05-06","completion_date":"2028-06-25","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07567365","publication_url":"https://clinicaltrials.gov/study/NCT07567365","title":"Clinical Outcomes of Focused Shockwave Therapy Without Adjunct Rehabilitation Compared to Standard Physical Rehabilitation in Patients With Grade I-III Knee Osteoarthritis: A Single-Blind Randomized Study","has_exemption":false,"start_date":"2027-09-25","completion_date":"2028-06-25","has_results":false,"results_due":false,"sponsor_name":"Pulse Wave USA","sponsor_slug":"pulse-wave-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04464226","publication_url":"https://clinicaltrials.gov/study/NCT04464226","title":"An Open-label, Single Arm, Roll-over Study to Provide Continued Treatment With Darolutamide in Participants Who Were Enrolled in Previous Bayer Sponsored Studies","has_exemption":false,"start_date":"2020-10-20","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06180278","publication_url":"https://clinicaltrials.gov/study/NCT06180278","title":"A Long-term, Open-label, Low-interventional Safety Study of Inebilizumab in the Treatment of NMOSD (N-MOmentum LT)","has_exemption":false,"start_date":"2024-04-02","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06925737","publication_url":"https://clinicaltrials.gov/study/NCT06925737","title":"A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (IDeate-Prostate01)","has_exemption":false,"start_date":"2025-05-13","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07571109","publication_url":"https://clinicaltrials.gov/study/NCT07571109","title":"Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Obstructive Sleep Apnoea Treated With Positive Airway Pressure (AMAZE 4)","has_exemption":false,"start_date":"2026-05-05","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07718581","publication_url":"https://clinicaltrials.gov/study/NCT07718581","title":"A Phase I/Ⅱa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HMPL-A830 in Solid Tumors","has_exemption":false,"start_date":"2026-08-15","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Hutchmed","sponsor_slug":"hutchmed","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06780670","publication_url":"https://clinicaltrials.gov/study/NCT06780670","title":"PSMAcTION: A Phase II/III, Open-label, International, Multicenter, Randomized Study of AAA817 Versus Standard of Care in the Treatment of Adult Participants With PSMA Positive Metastatic Castration-resistant Prostate Cancer Who Progressed on or After [177Lu]Lu-PSMA Targeted Therapy","has_exemption":false,"start_date":"2025-02-27","completion_date":"2028-06-27","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07742644","publication_url":"https://clinicaltrials.gov/study/NCT07742644","title":"A Phase 3a, Observer-blind, Randomized, Controlled Study to Demonstrate Lot-to-lot Consistency and Evaluate the Immunogenicity and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine Compared With ProQuad, Administered as a Second Dose in Healthy Children 4-6 Years of Age","has_exemption":false,"start_date":"2026-08-11","completion_date":"2028-06-27","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07720271","publication_url":"https://clinicaltrials.gov/study/NCT07720271","title":"Efficacy and Safety of Once-daily Oral Zenagamtide in Participants With Obesity (AMAZE 9)","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-06-27","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06319820","publication_url":"https://clinicaltrials.gov/study/NCT06319820","title":"A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (IR-NMIBC) and Susceptible FGFR Alterations","has_exemption":false,"start_date":"2024-04-18","completion_date":"2028-06-28","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07190196","publication_url":"https://clinicaltrials.gov/study/NCT07190196","title":"A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease","has_exemption":false,"start_date":"2025-09-26","completion_date":"2028-06-28","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03137472","publication_url":"https://clinicaltrials.gov/study/NCT03137472","title":"Transcranial Magnetic Stimulation (TMS) for Complex Regional Pain Syndrome (CRPS)","has_exemption":false,"start_date":"2017-04-24","completion_date":"2028-06-29","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672459","publication_url":"https://clinicaltrials.gov/study/NCT05672459","title":"A Phase 1/2a, Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors","has_exemption":false,"start_date":"2023-06-21","completion_date":"2028-06-29","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224360","publication_url":"https://clinicaltrials.gov/study/NCT07224360","title":"Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease","has_exemption":false,"start_date":"2026-02-02","completion_date":"2028-06-29","has_results":false,"results_due":false,"sponsor_name":"CSL Behring","sponsor_slug":"csl-behring","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00494728","publication_url":"https://clinicaltrials.gov/study/NCT00494728","title":"Smoking Cessation Intervention for Depressed Smokers: Treatment Development","has_exemption":false,"start_date":"2007-06-28","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01000350","publication_url":"https://clinicaltrials.gov/study/NCT01000350","title":"Intravenous Saline on Exercise Tolerance in Orthostatic Intolerance","has_exemption":false,"start_date":"2009-10-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01446133","publication_url":"https://clinicaltrials.gov/study/NCT01446133","title":"Combination of Lenalidomide and Rituximab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) as Initial Treatment or Subsequent Therapy","has_exemption":false,"start_date":"2011-12-12","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02007044","publication_url":"https://clinicaltrials.gov/study/NCT02007044","title":"Ibrutinib vs Ibrutinib + Rituximab (i vs iR) in Patients With Relapsed (CLL)","has_exemption":false,"start_date":"2013-12-06","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02064673","publication_url":"https://clinicaltrials.gov/study/NCT02064673","title":"Randomized Trial of Adjuvant Curcumin After Prostatectomy","has_exemption":false,"start_date":"2014-05-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Yair Lotan","sponsor_slug":"yair-lotan","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02942355","publication_url":"https://clinicaltrials.gov/study/NCT02942355","title":"Pilot Trial of Anastrozole and Palbociclib as First-Line Therapy and as Maintenance Therapy After First Line Chemotherapy in Hormone Receptor Positive, HER2-Negative Postmenopausal Metastatic Breast Cancer","has_exemption":false,"start_date":"2016-12-07","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03213002","publication_url":"https://clinicaltrials.gov/study/NCT03213002","title":"Phase I/II Study of Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed Glioblastoma (GBM)","has_exemption":false,"start_date":"2017-06-13","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03175432","publication_url":"https://clinicaltrials.gov/study/NCT03175432","title":"Phase II Study of BEvacizumab (Avastin) in Combination With Atezolizumab or Atezolizumab (Tencentriq) and Cobimetinib (Cotellic) in Patients With Untreated Melanoma Brain Metastases (TACo-BEAT-MBM)","has_exemption":false,"start_date":"2017-06-15","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03238690","publication_url":"https://clinicaltrials.gov/study/NCT03238690","title":"Sequential Left Ventricular Assist Device (LVAD) Unloading and Conditioning to Induce Sustained Cardiac Recovery","has_exemption":false,"start_date":"2017-06-23","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"STAVROS G DRAKOS","sponsor_slug":"stavros-g-drakos","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03110978","publication_url":"https://clinicaltrials.gov/study/NCT03110978","title":"Phase II Randomized Clinical Trials Comparing Immunotherapy Plus Stereotactic Ablative Radiotherapy (I-SABR) Versus SABR Alone for Stage I, Selected Stage IIa, or Isolated Lung Parenchymal Recurrent Non-Small Cell Lung Cancer: I-SABR","has_exemption":false,"start_date":"2017-06-26","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03767348","publication_url":"https://clinicaltrials.gov/study/NCT03767348","title":"An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination With PD1 Blockade in Patients With Solid Tumors [IGNYTE]","has_exemption":false,"start_date":"2017-09-20","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Replimune Inc.","sponsor_slug":"replimune-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03457493","publication_url":"https://clinicaltrials.gov/study/NCT03457493","title":"UAB Neuroinflammation in Parkinson's Disease - TSPO-PET Substudy","has_exemption":false,"start_date":"2018-03-22","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01818661","publication_url":"https://clinicaltrials.gov/study/NCT01818661","title":"Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech","has_exemption":false,"start_date":"2018-07-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03539822","publication_url":"https://clinicaltrials.gov/study/NCT03539822","title":"A Phase I/II Trial of Cabozantinib in Combination With Durvalumab (MEDI4736) With or Without Tremelimumab in Patients With Advanced Gastroesophageal Cancer and Other Gastrointestinal (GI) Malignancies (CAMILLA)","has_exemption":false,"start_date":"2018-10-22","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Anwaar Saeed","sponsor_slug":"anwaar-saeed","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03933631","publication_url":"https://clinicaltrials.gov/study/NCT03933631","title":"A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery","has_exemption":false,"start_date":"2019-05-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03970447","publication_url":"https://clinicaltrials.gov/study/NCT03970447","title":"GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM","has_exemption":false,"start_date":"2019-07-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Global Coalition for Adaptive Research","sponsor_slug":"global-coalition-for-adaptive-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03971487","publication_url":"https://clinicaltrials.gov/study/NCT03971487","title":"Ocrelizumab for Psychoses Possibly Caused by Synaptic Autoimmunity","has_exemption":false,"start_date":"2019-10-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115254","publication_url":"https://clinicaltrials.gov/study/NCT04115254","title":"A Master Protocol of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART)","has_exemption":false,"start_date":"2019-10-22","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04198454","publication_url":"https://clinicaltrials.gov/study/NCT04198454","title":"Randomized, Investigator-blinded Study of Compression in Wound Healing With and Without Fractional Ablative CO2 Laser After Excisions on the Lower Extremity (CHIME+)","has_exemption":false,"start_date":"2020-02-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04543071","publication_url":"https://clinicaltrials.gov/study/NCT04543071","title":"A Phase 2 Study With Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Chemokine (C-X-C) Motif Receptor 4 Inhibitor (BL-8040), and Immune Checkpoint Blockade (Cemiplimab) in METastatic Treatment naïve PANCreas Adenocarcinoma","has_exemption":false,"start_date":"2020-11-09","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Gulam Manji","sponsor_slug":"gulam-manji","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04005469","publication_url":"https://clinicaltrials.gov/study/NCT04005469","title":"A Phase I/II Study Evaluating the Preliminary Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During De Novo Adult Kidney Transplantation","has_exemption":false,"start_date":"2020-11-13","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04546399","publication_url":"https://clinicaltrials.gov/study/NCT04546399","title":"A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC# 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse","has_exemption":false,"start_date":"2020-12-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04576156","publication_url":"https://clinicaltrials.gov/study/NCT04576156","title":"A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat (GRN163L) Versus Best Available Therapy (BAT) in Patients With Intermediate-2 or High-risk Myelofibrosis (MF) Relapsed / Refractory (R/R) to Janus Kinase (JAK) Inhibitor","has_exemption":false,"start_date":"2021-04-12","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Geron Corporation","sponsor_slug":"geron-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04977453","publication_url":"https://clinicaltrials.gov/study/NCT04977453","title":"A Phase 1/2, Open-label, Dose-escalation, Dose-optimization and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Therapeutic Activity of GI-101/GI-101A as a Single Agent and in Combination With Pembrolizumab or Lenvatinib in Patients With Advanced or Metastatic Solid Tumors (Keynote B59)","has_exemption":false,"start_date":"2021-08-02","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"GI Innovation, Inc.","sponsor_slug":"gi-innovation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04851119","publication_url":"https://clinicaltrials.gov/study/NCT04851119","title":"A Phase 1/2 Study of Tegavivint (NSC#826393) in Children, Adolescents, and Young Adults With Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors","has_exemption":false,"start_date":"2021-11-08","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04838041","publication_url":"https://clinicaltrials.gov/study/NCT04838041","title":"Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation","has_exemption":false,"start_date":"2021-11-11","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04873037","publication_url":"https://clinicaltrials.gov/study/NCT04873037","title":"A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Overactive Bladder","has_exemption":false,"start_date":"2021-11-22","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04892173","publication_url":"https://clinicaltrials.gov/study/NCT04892173","title":"A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination With Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients With Locally Advanced Head & Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2021-12-10","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Johnson & Johnson Enterprise Innovation Inc.","sponsor_slug":"johnson-johnson-enterprise-innovation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04500756","publication_url":"https://clinicaltrials.gov/study/NCT04500756","title":"LIMItIng AAA With meTformin (LIMIT) Trial","has_exemption":false,"start_date":"2022-02-28","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05036707","publication_url":"https://clinicaltrials.gov/study/NCT05036707","title":"Investigating the Human Immune Response to Ixodes Scapularis Tick Bites","has_exemption":false,"start_date":"2022-02-28","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05249634","publication_url":"https://clinicaltrials.gov/study/NCT05249634","title":"Effect of JATENZO® Therapy on Testosterone and Hemoglobin Concentrations in Hypogonadal Men With Chronic Kidney Disease","has_exemption":false,"start_date":"2022-03-15","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"St. Louis University","sponsor_slug":"st-louis-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05208190","publication_url":"https://clinicaltrials.gov/study/NCT05208190","title":"Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial","has_exemption":false,"start_date":"2022-03-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05147792","publication_url":"https://clinicaltrials.gov/study/NCT05147792","title":"An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendage Occlusion","has_exemption":false,"start_date":"2022-05-26","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Conformal Medical, Inc","sponsor_slug":"conformal-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05296070","publication_url":"https://clinicaltrials.gov/study/NCT05296070","title":"A Phase 2, Open-label, Study Evaluating Safety and Efficacy of the Loncastuximab in Relapsed/Refractory Marginal Zone Lymphoma","has_exemption":false,"start_date":"2022-06-21","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05426733","publication_url":"https://clinicaltrials.gov/study/NCT05426733","title":"An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children With Biliary Atresia (BOLD-EXT)","has_exemption":false,"start_date":"2022-07-05","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Albireo, an Ipsen Company","sponsor_slug":"albireo-an-ipsen-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05180773","publication_url":"https://clinicaltrials.gov/study/NCT05180773","title":"Randomized Evaluation of Bromocriptine In Myocardial Recovery THerapy for Peripartum Cardiomyopathy (REBIRTH)","has_exemption":false,"start_date":"2022-07-27","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Dennis M. McNamara, MD, MS","sponsor_slug":"dennis-m-mcnamara-md-ms","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05319314","publication_url":"https://clinicaltrials.gov/study/NCT05319314","title":"A Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of LYL273 in Patients With Relapsed or Refractory Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2022-08-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Lyell Immunopharma, Inc.","sponsor_slug":"lyell-immunopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05502237","publication_url":"https://clinicaltrials.gov/study/NCT05502237","title":"A Randomized, Open-Label, Phase 3 Study to Evaluate Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer With No Epidermal Growth Factor Receptor or Anaplastic Lymphoma Kinase Genomic Tumor Aberrations","has_exemption":false,"start_date":"2022-10-12","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05639907","publication_url":"https://clinicaltrials.gov/study/NCT05639907","title":"A Comparison of Miniscrew Stability and Peri-implant Inflammation When Precoated With Antimicrobial Quaternary Ammonium Compound K21 vs Ethanol Control in Orthodontic Patients: a Triple-blind, Split-mouth, Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2022-11-11","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05475171","publication_url":"https://clinicaltrials.gov/study/NCT05475171","title":"Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)","has_exemption":false,"start_date":"2022-12-13","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05645536","publication_url":"https://clinicaltrials.gov/study/NCT05645536","title":"Open-label, Safety Extension Study for Subjects With HR+, HER2-Negative Breast Cancer Who Have Completed the OVarian Suppression Evaluating Subcutaneous LeuprolIde Acetate in Breast Cancer OVELIA Study","has_exemption":false,"start_date":"2022-12-28","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Tolmar Inc.","sponsor_slug":"tolmar-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05580562","publication_url":"https://clinicaltrials.gov/study/NCT05580562","title":"ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study","has_exemption":false,"start_date":"2023-01-23","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05701774","publication_url":"https://clinicaltrials.gov/study/NCT05701774","title":"An Open-Label Study of DCCR (Diazoxide Choline) Extended-Release Tablets in Patients With Prader-Willi Syndrome","has_exemption":false,"start_date":"2023-01-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Soleno Therapeutics, Inc.","sponsor_slug":"soleno-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04930887","publication_url":"https://clinicaltrials.gov/study/NCT04930887","title":"Prospective, Randomized, Double-blinded, Placebo-controlled, Cross-over Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) Towards the Ipsilateral Pterygopalatine Fossa for the Treatment of Craniofacial Pain","has_exemption":false,"start_date":"2023-02-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05461547","publication_url":"https://clinicaltrials.gov/study/NCT05461547","title":"Pre-Hospital Lung Ultrasound Impact on Diagnosis","has_exemption":false,"start_date":"2023-02-09","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05685238","publication_url":"https://clinicaltrials.gov/study/NCT05685238","title":"Open-label, Long-term Safety and Efficacy Study of Mim8 in Participants With Haemophilia A With or Without Inhibitors","has_exemption":false,"start_date":"2023-02-13","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05317000","publication_url":"https://clinicaltrials.gov/study/NCT05317000","title":"A Window Trial of 5-Azacytidine or Nivolumab or Combination Nivolumab Plus 5-Azacytidine in Resectable HPV-Associated Head and Neck Squamous Cell Cancer","has_exemption":false,"start_date":"2023-03-23","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Barbara Burtness","sponsor_slug":"barbara-burtness","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05239546","publication_url":"https://clinicaltrials.gov/study/NCT05239546","title":"Phase II, Single Arm Study of Neoadjuvant Dostarlimab (TSR-042) in Stage II and III Deficient Mismatch Repair Colon Cancers","has_exemption":false,"start_date":"2023-03-24","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05786924","publication_url":"https://clinicaltrials.gov/study/NCT05786924","title":"A Phase 1/2, Open-label Study of Oral S241656 (BDTX-4933) as Monotherapy and in Combination With Other Anti-Cancer Therapies in Patients With KRAS, BRAF and Other Selected RAS/MAPK Mutation-Positive Malignancies","has_exemption":false,"start_date":"2023-04-18","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Institut de Recherches Internationales Servier","sponsor_slug":"institut-de-recherches-internationales-servier","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05732103","publication_url":"https://clinicaltrials.gov/study/NCT05732103","title":"Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients With Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2023-04-25","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Chordia Therapeutics, Inc.","sponsor_slug":"chordia-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05898399","publication_url":"https://clinicaltrials.gov/study/NCT05898399","title":"A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of the DNA Polymerase Theta Inhibitor ART6043 Administered Orally as Monotherapy and in Combination to Patients With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2023-06-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Artios Pharma Ltd","sponsor_slug":"artios-pharma-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05858632","publication_url":"https://clinicaltrials.gov/study/NCT05858632","title":"Immune Spatial Features of Guselkumab Cutaneous Response","has_exemption":false,"start_date":"2023-07-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05956951","publication_url":"https://clinicaltrials.gov/study/NCT05956951","title":"Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Closed-Loop Auditory Stimulation","has_exemption":false,"start_date":"2023-07-20","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Fabio Ferrarelli","sponsor_slug":"fabio-ferrarelli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05981755","publication_url":"https://clinicaltrials.gov/study/NCT05981755","title":"Breathing Rescue for SUDEP Prevention (BreatheS)","has_exemption":false,"start_date":"2023-07-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06013956","publication_url":"https://clinicaltrials.gov/study/NCT06013956","title":"Identifying Circuit Dynamics Underlying Motor Dysfunction in Parkinson's Disease Using Real-Time Neural Control","has_exemption":false,"start_date":"2023-08-29","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"David Escobar","sponsor_slug":"david-escobar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05883748","publication_url":"https://clinicaltrials.gov/study/NCT05883748","title":"HELIOS: An Open-Label, Long-Term Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)","has_exemption":false,"start_date":"2023-08-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Disc Medicine, Inc","sponsor_slug":"disc-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06033599","publication_url":"https://clinicaltrials.gov/study/NCT06033599","title":"Motivational Interviewing (MI) and Mindfulness-Oriented Recovery Enhancement (MORE) for Tobacco Dependence and Other Drug Use in Methadone Treatment","has_exemption":false,"start_date":"2023-09-05","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05796453","publication_url":"https://clinicaltrials.gov/study/NCT05796453","title":"Long-term Evaluation of Safety and Performance of Clareon Presbyopia-Correcting Intraocular Lenses (IOLs)","has_exemption":false,"start_date":"2023-09-19","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05920798","publication_url":"https://clinicaltrials.gov/study/NCT05920798","title":"MC220601, Folate Receptor Alpha Dendritic Cells (FRαDCs) Plus Pembrolizumab for Patients With Advanced Stage Ovarian Cancer (FRAPPE)","has_exemption":false,"start_date":"2023-09-28","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05858645","publication_url":"https://clinicaltrials.gov/study/NCT05858645","title":"Correction of Psoriatic T Cell Signatures by Deucravacitinib","has_exemption":false,"start_date":"2023-10-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05478707","publication_url":"https://clinicaltrials.gov/study/NCT05478707","title":"Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes","has_exemption":false,"start_date":"2023-10-05","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"AdventHealth Translational Research Institute","sponsor_slug":"adventhealth-translational-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06001918","publication_url":"https://clinicaltrials.gov/study/NCT06001918","title":"Randomized Controlled Clinical Trial (RCT) of the Nectero EAST System for Small to Mid-Sized Abdominal Aortic Aneurysms (AAA) StaBiLization: Evaluation of Efficacy.","has_exemption":false,"start_date":"2023-10-25","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Nectero Medical, Inc.","sponsor_slug":"nectero-medical-inc","status":"ongoing","is_pact":false,"days_late":null}]}